Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

NCT04912115 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped Seeking Pivotal study initiation

Conditions

Dyskinesias
Movement Disorders
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations

Interventions

DRUG: Ketamine
DRUG: Midazolam

Sponsor

PharmaTher Inc.